A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection
- PMID: 15823423
- DOI: 10.1016/j.neulet.2004.12.080
A role for hypoxia-inducible factor-1alpha in desferoxamine neuroprotection
Abstract
The newborn brain has increased vulnerability to hypoxia-ischemia from maturational differences in the oxidative stress response. We hypothesized that desferoxamine (DFO), an iron chelator, would provide protection in an in vitro model of ischemia in part through activation of the hypoxia-inducible gene hypoxia-inducible factor-1alpha (HIF-1alpha). Hippocampal neurons from E16 CD1 mice were exposed to 3 h of oxygen and glucose deprivation with and without pretreatment with 10 mmol/L DFO in the presence and absence of 2 micromol/L antisense oligonucleotides specific for HIF-1alpha (antiHIF-1alpha). DFO pretreatment resulted in 45% reduction in cell death (p = 0.006). This protection was diminished with transfection of antiHIF-1alpha (p = 0.049). Blocking HIF-1alpha reduces DFO protection suggesting that DFO protects through iron chelation and HIF-1alpha induction.
Similar articles
-
Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.Neurosci Bull. 2008 Apr;24(2):89-95. doi: 10.1007/s12264-008-0089-3. Neurosci Bull. 2008. PMID: 18369388 Free PMC article.
-
Methylene blue-induced neuronal protective mechanism against hypoxia-reoxygenation stress.Neuroscience. 2015 Aug 20;301:193-203. doi: 10.1016/j.neuroscience.2015.05.064. Epub 2015 Jun 3. Neuroscience. 2015. PMID: 26047733 Free PMC article.
-
Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.Br J Pharmacol. 2004 Mar;141(6):988-96. doi: 10.1038/sj.bjp.0705687. Epub 2004 Feb 23. Br J Pharmacol. 2004. PMID: 14980978 Free PMC article.
-
Advances in Hypoxia-Inducible Factor-1α Stabilizer Deferoxamine in Tissue Engineering.Tissue Eng Part B Rev. 2023 Aug;29(4):347-357. doi: 10.1089/ten.TEB.2022.0168. Epub 2023 Feb 1. Tissue Eng Part B Rev. 2023. PMID: 36475887 Review.
-
Pharmacological regulation of HIF-1α, RGC death, and glaucoma.Curr Opin Pharmacol. 2024 Aug;77:102467. doi: 10.1016/j.coph.2024.102467. Epub 2024 Jun 18. Curr Opin Pharmacol. 2024. PMID: 38896924 Review.
Cited by
-
Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-kappaB in immortalized and malignant oral keratinocytes.BMC Cancer. 2007 Sep 13;7:176. doi: 10.1186/1471-2407-7-176. BMC Cancer. 2007. PMID: 17850672 Free PMC article.
-
Elevated cell invasion is induced by hypoxia in a human pituitary adenoma cell line.Cell Adh Migr. 2007 Jan-Mar;1(1):43-51. Epub 2007 Jan 27. Cell Adh Migr. 2007. PMID: 19262092 Free PMC article.
-
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.BMC Med Genomics. 2009 Jan 8;2:2. doi: 10.1186/1755-8794-2-2. BMC Med Genomics. 2009. PMID: 19133145 Free PMC article.
-
Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: model for the potential involvement of the hypoxia-inducible factor pathway in Parkinson disease.J Biol Chem. 2009 Oct 16;284(42):29065-76. doi: 10.1074/jbc.M109.000638. Epub 2009 Aug 13. J Biol Chem. 2009. PMID: 19679656 Free PMC article.
-
Traumatic injury to the immature brain: inflammation, oxidative injury, and iron-mediated damage as potential therapeutic targets.NeuroRx. 2006 Apr;3(2):143-53. doi: 10.1016/j.nurx.2006.01.006. NeuroRx. 2006. PMID: 16554253 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
